We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TLS:ASXTelstra Group Limited Analysis

Data as of 2026-07-30 - not real-time

A$5.06

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Telstra (TLS) is trading at AUD 5.06, just above its 200‑day SMA (5.06) and slightly below the 50‑day SMA (5.09), indicating a neutral technical stance. The RSI sits at 53, suggesting neither over‑bought nor over‑sold conditions, while the MACD histogram is modestly positive, giving a faint bullish signal. Price action is bounded by a clear support level around 4.80 and resistance near 5.10, with volume trending upward, which adds short‑term liquidity confidence. Fundamentally, the stock commands a PE of 25.3 versus an industry average of 15.9, and a P/B of 4.31, pointing to a premium valuation that is not fully justified by its modest 0.3% revenue growth and flat EPS outlook. The dividend yield of 4.15% is attractive, but the payout ratio of roughly 96% raises concerns about sustainability, especially given a high debt‑to‑equity ratio of 119% and total debt of AUD 18.75 bn. Operating cash flow remains robust (AUD 7.8 bn) and free cash flow is healthy (AUD 3.9 bn), yet the balance sheet leverage and limited growth tilt the risk‑reward balance toward caution. The 30‑day volatility of about 20% and an almost neutral beta (‑0.01) suggest price swings are driven more by company‑specific factors than market movements. Recent news highlights Telstra’s defensive profile and dividend appeal, reinforcing its perception as a “defensive dividend” play but offering little new catalyst for upside. Overall, the stock appears slightly overvalued, with defensive merits offset by valuation pressure and leverage concerns.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near short‑term resistance with modest bullish MACD
  • Strong dividend yield but high payout ratio
  • Increasing volume supporting liquidity

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Valuation premium relative to peers
  • Robust operating cash flow offset by high debt load
  • Limited revenue growth and flat EPS guidance

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Significant overvaluation versus DCF fair value
  • Elevated leverage and debt‑to‑equity ratio
  • Unsustainable dividend payout in a low‑growth environment

Key Metrics & Analysis

Financial Health

Revenue Growth0.30%
Profit Margin9.80%
P/E Ratio25.3
ROE14.75%
ROA5.85%
Debt/Equity119.14
P/B Ratio4.3
Op. Cash FlowA$7.8B
Free Cash FlowA$3.9B
Industry P/E15.9

Technical Analysis

TrendNeutral
RSI53.4
SupportA$4.80
ResistanceA$5.10
MA 20A$4.97
MA 50A$5.09
MA 200A$5.06
MACDBullish
VolumeIncreasing
Fear & Greed Index84.54

Valuation

Fair ValueA$3.03
Target PriceA$5.22
Upside/Downside3.22%
GradeOvervalued
TypeValue
Dividend Yield4.15%

Risk Assessment

Beta-0.01
Volatility19.93%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.